I think the main hindrance for the price to go higher and all the way up is the budget whether can pass through as warned by AI to reject..unless PN can resolve this issue....
IF SELECTED, we will only do the packaging. After that we will give it back to government to distribute to the people. I just scared when the government will announce that vaccine will be free for all.
Well no matter how good the news is, economy is still shattered af, and the KLCI soon to reach the peak before MCO at March, time to take some profit first.
NO matter vaccine news is related to Msia or not. Effective or not. THe fact from monitoring TA Chart, vaccine relevant stock is much better than Glove counters.
Same ol story as Putin Vaccine but until today no vaccine but the case in Russia keep increase. Vaccine will be available next year end of 2021 for Malaysia. Dont high hope on politician talk.
Lets be confident to our scientist involving in the vaccines development, they are working very hard for it now to save people's life and the world economy. Its a serious job and no mistake is allowed, thus we have to be patience with it..Putin just commented that their vaccines development is so far still on track.
Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.
-----------
US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.
Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.
The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.
Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.
But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."
VACCINE IS A HOAX LA....ONCE IS INJECTED TO US POPULATION, SURE A LOT PPL DEVELOP SYMPTOM AND ADVERSR EFFECT...DUN TRUST JUST WAIT SEE....FAST TRACK IS ALWAYS USELESS AND NOT SAFE...
Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.
------------ Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts
The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."
Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.
They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.
Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.
LONDON (Nov 10): News of a breakthrough in the race to find a Covid-19 vaccine sparked one of the heaviest trading days since the height of the pandemic crisis, according to early data analysed by Reuters, with nearly US$2 trillion changing hands on Monday.
Pzifer and US politics are interlink { announcement made right after Joe wins } this is to ensure US pharmaceutical firms are in the eyes of the public
SUICIDE halts Brazil trial of Chinese vaccine attacked by Bolsonaro
The trial’s organizers criticized Anvisa’s decision, saying they had not been notified in advance and that there was no reason to stop the trial.
Although a trial volunteer had died, it had nothing to do with the vaccine, Jean Gorinchteyn, Health Secretary for the state of Sao Paulo told a news conference on Tuesday.
“We had an external event that led to the regulator being notified,” Gorinchteyn said. “This vaccine is safe.”
Dimas Covas, the head of Sao Paulo’s medical research institute Butantan, which is conducting the Sinovac trial, said the vaccine had shown no serious adverse effects. Speaking at the same news conference, he said he hoped the trial would be resumed later on Tuesday or Wednesday.
Anvisa said the initial information it received from Butantan had not specified that the death was a SUICIDE.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Jonathan Keung
4,421 posts
Posted by Jonathan Keung > 2020-11-10 08:35 | Report Abuse
Pharma and DPharma main beneficiaries whether China or US vaccines